IQVIA Q3 FY25: where the revenue came from and where it went
The whole income statement of IQVIA for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Oct 28, 2025
Revenue$4.10B
+5% year over year
Gross profit$1.37B
33% margin
Operating profit$0.55B
13% margin
Net profit$0.33B
8% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.10 | 100% | +5% |
| Research & development | 2.26 | 55% | +5% |
| Technology & analytics | 1.63 | 40% | +5% |
| Contract sales & medical | 0.21 | 5% | +16% |
| Cost of revenue | −2.73 | 67% | |
| Gross profit | 1.37 | 33% margin | +10pp |
| SG&A | −0.51 | 13% | −1pp |
| Other | −0.31 | 7% | +0pp |
| Operating profit | 0.55 | 13% margin | −1pp |
| Interest & other costs | −0.15 | ||
| Tax | −0.08 | ||
| Net profit | 0.33 | 8% margin | +1pp |
357 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest